Capricor Therapeutics ROE 2006-2019 | CAPR

Current and historical return on equity (ROE) values for Capricor Therapeutics (CAPR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Capricor Therapeutics ROE for the three months ending March 31, 2019 was -225.30%.
Capricor Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.01B $0.00B -215.38%
2018-12-31 $-0.02B $0.01B -181.82%
2018-09-30 $0.00B $0.01B 0.00%
2018-06-30 $0.00B $0.01B 14.29%
2018-03-31 $0.00B $0.01B 72.73%
2017-12-31 $0.00B $0.01B -114.29%
2017-09-30 $-0.02B $-0.00B 272.73%
2017-06-30 $-0.02B $-0.01B 377.78%
2017-03-31 $-0.02B $-0.01B 475.00%
2016-12-31 $-0.02B $-0.00B 760.00%
2016-09-30 $-0.02B $0.00B 971.43%
2016-06-30 $-0.02B $-0.01B 1200.00%
2016-03-31 $-0.01B $-0.00B -1040.00%
2015-12-31 $-0.01B $-0.00B -369.23%
2015-09-30 $-0.01B $0.00B -550.00%
2015-06-30 $-0.01B $0.01B -2000.00%
2015-03-31 $-0.01B $0.01B 600.00%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $-0.00B 360.00%
2014-06-30 $-0.01B $-0.00B 450.00%
2014-03-31 $-0.01B $-0.00B 600.00%
2013-12-31 $-0.01B $-0.00B 720.00%
2013-09-30 $-0.01B $-0.00B -2000.00%
2013-06-30 $-0.00B $-0.00B -533.33%
2013-03-31 $-0.00B $-0.00B -160.00%
2012-12-31 $-0.00B $0.01B -133.33%
2012-09-30 $-0.00B $0.00B -800.00%
2012-06-30 $-0.00B $0.00B -400.00%
2012-03-31 $-0.01B $0.00B -333.33%
2011-12-31 $-0.01B $0.00B -250.00%
2011-09-30 $-0.00B $0.00B -160.00%
2011-06-30 $-0.01B $0.00B -181.82%
2011-03-31 $-0.01B $0.00B -153.85%
2010-12-31 $-0.01B $0.00B -200.00%
2010-09-30 $-0.01B $0.00B -233.33%
2010-06-30 $-0.01B $0.01B -215.38%
2010-03-31 $-0.01B $0.00B -360.00%
2009-12-31 $-0.01B $0.00B -300.00%
2009-09-30 $-0.01B $0.00B -285.71%
2009-06-30 $-0.01B $0.00B -258.82%
2009-03-31 $-0.01B $0.00B -192.00%
2008-12-31 $-0.01B $0.01B -148.57%
2008-09-30 $-0.01B $0.01B -115.56%
2008-06-30 $-0.02B $0.01B -116.36%
2008-03-31 $-0.01B $0.01B -115.56%
2007-12-31 $-0.01B $0.02B -137.50%
2007-09-30 $-0.01B $0.02B -235.29%
2007-06-30 $-0.01B $0.00B inf%
2007-03-31 $-0.00B $0.00B inf%
2006-12-31 $-0.00B $0.00B inf%
2006-09-30 $-0.00B $0.00B inf%
2006-06-30 $0.00B $0.00B nan%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.020B $0.002B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.82
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.28
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.543B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.04
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
MRI INTERVENTNS (MRIC) United States $0.052B 0.00